These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35566035)

  • 1. Pathophysiological Role and Medicinal Chemistry of A
    Merighi S; Borea PA; Varani K; Vincenzi F; Travagli A; Nigro M; Pasquini S; Suresh RR; Kim SW; Volkow ND; Jacobson KA; Gessi S
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A
    Merighi S; Borea PA; Varani K; Vincenzi F; Jacobson KA; Gessi S
    Curr Med Chem; 2022; 29(24):4138-4151. PubMed ID: 34844537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adenosine A
    Launay A; Nebie O; Vijaya Shankara J; Lebouvier T; Buée L; Faivre E; Blum D
    Neuropharmacology; 2023 Mar; 226():109379. PubMed ID: 36572177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A
    Gessi S; Poloni TE; Negro G; Varani K; Pasquini S; Vincenzi F; Borea PA; Merighi S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Istradefylline reduces memory deficits in aging mice with amyloid pathology.
    Orr AG; Lo I; Schumacher H; Ho K; Gill M; Guo W; Kim DH; Knox A; Saito T; Saido TC; Simms J; Toddes C; Wang X; Yu GQ; Mucke L
    Neurobiol Dis; 2018 Feb; 110():29-36. PubMed ID: 29100987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Merighi S; Nigro M; Travagli A; Pasquini S; Borea PA; Varani K; Vincenzi F; Gessi S
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A
    Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
    Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
    Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease.
    Merighi S; Battistello E; Casetta I; Gragnaniello D; Poloni TE; Medici V; Cirrincione A; Varani K; Vincenzi F; Borea PA; Gessi S
    J Alzheimers Dis; 2021; 80(3):1105-1117. PubMed ID: 33646165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A
    Lambertucci C; Marucci G; Catarzi D; Colotta V; Francucci B; Spinaci A; Varano F; Volpini R
    Curr Med Chem; 2022 Aug; 29(28):4780-4795. PubMed ID: 35184706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine receptor signalling in Alzheimer's disease.
    Trinh PNH; Baltos JA; Hellyer SD; May LT; Gregory KJ
    Purinergic Signal; 2022 Sep; 18(3):359-381. PubMed ID: 35870032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of adenosine A
    Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
    Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of cannabinoid signaling in microglia by adenosine A
    Franco R; Reyes-Resina I; Aguinaga D; Lillo A; Jiménez J; Raïch I; Borroto-Escuela DO; Ferreiro-Vera C; Canela EI; Sánchez de Medina V; Del Ser-Badia A; Fuxe K; Saura CA; Navarro G
    Glia; 2019 Dec; 67(12):2410-2423. PubMed ID: 31429130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ
    Dias L; Madeira D; Dias R; Tomé ÂR; Cunha RA; Agostinho P
    Cell Mol Life Sci; 2022 Jul; 79(8):457. PubMed ID: 35907034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine for Prevention of Alzheimer's Disease: Is the A
    Merighi S; Travagli A; Nigro M; Pasquini S; Cappello M; Contri C; Varani K; Vincenzi F; Borea PA; Gessi S
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered motility of plaque-associated microglia in a model of Alzheimer's disease.
    Gyoneva S; Swanger SA; Zhang J; Weinshenker D; Traynelis SF
    Neuroscience; 2016 Aug; 330():410-20. PubMed ID: 27288150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.